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Abstract: The present work aimed to characterize leaves, stems, and flowers of Carissa macrocarpa
(Eckl.) A.DC., by performing an analysis of the phenolic compounds by HPLC-DAD/ESI-MS,
correlating them with bioactive properties, such as antioxidant, anti-inflammatory, cytotoxic, and
antimicrobial activities. Thirty polyphenols were identified in the hydroethanolic extract, including
phenolic acids, flavan-3-ols, and flavonol glycosides derivatives (which presented the highest number
of identified compounds). However, flavan-3-ols showed the highest concentration in stems (mainly
owing to the presence of dimers, trimmers, and tetramers of type B (epi)catechin). Leaves were
distinguished by their high antioxidant and anti-inflammatory activities, as well as their bactericidal
effect against E. coli, while stems presented a higher cytotoxic activity and bactericidal effect against
Gram-positive bacteria. Moreover, a high correlation between the studied bioactivities and the
presence of phenolic compounds was also verified. The obtained results bring added value to the
studied plant species.
Keywords: Carissa macrocarpa; plant aerial parts; phenolic profile; bioactivities; Pearson’s correlation
1. Introduction
The genus Carissa belongs to the family of Apocynaceae, which normally has a high content of
phenolic compounds, such as flavonoids, as well as lignans and sesquiterpenes. Accordingly, this
plant genus presents several therapeutic applications such as antioxidant, analgesic, anti-inflammatory,
hypolipidemic, wound healing, antimicrobial, antidiabetic, antiepileptic, anti-cancer, diuretic,
hepatoprotective, and improvement of nephrotoxicity [1].
Carissa macrocarpa (Eckl.) A.DC. (syn: C. grandiflora (E.Mey.) A.DC.) is a native plant from
South Africa, KwaZulu-Natal, commonly known as Natal plum [2,3]. It is an ornamental shrub,
characterized by large, green, lush, and persistent leaves; star-shaped and white flowers; and edible
oval fruits [3,4]. The ripe fruits are delicious and can be used for the preparation of jams, sauces,
desserts, yogurt, jellies, and ice cream, while this plant is also used in traditional medicine for the
treatment of diarrhea in livestock, cough, and venereal diseases [5,6]. C. macrocarpa leaves, stems, and
roots present antioxidant and antimicrobial activities [3,4], and the leaves present cytotoxic activity [7],
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owing to the presence of various secondary metabolites, such as flavonoids, saponins, triterpenoids,
anthraquinones, and tannins
The presence of different phenolic compounds, such as flavonoids, hydroxycinnamic and
hydroxybenzoic acids, coumarins, xanthones, chalcones, stilbenes, lignins, and lignans have been
described in numerous publications regarding the phenolic profile of the genus Carissa. These
compounds are known for their important role in cancer treatment [8], hepatoprotective effects [9], and
antifungal properties [10]. Some of these biological properties are directly related to the antioxidant
activity of these compounds, in accordance with that described by Martins et al. [10].
To the author’s best knowledge, there are no previous studies describing the anti-inflammatory
activity of C. macrocarpa leaves, stems, or flowers, and only few studies could be found regarding
antioxidant, cytotoxic, and antibacterial properties of different extracts obtained from leaves and stems.
Moreover, there is no report on C. macrocarpa flowers. Therefore, the aim of the present study was
to established the individual phenolic profile of the hydroethanolic extracts obtained from leaves,
stems, and flowers of C. macrocarpa, being further correlated with their antioxidant, antibacterial,
anti-inflammatory, and cytotoxic properties.
2. Results and Discussion
2.1. Phenolic Profile of the Aerial Parts of C. Macrocarpa
Table 1 presents the chromatographic characteristics (obtained by HPLC-DAD/ESI-MS) and
tentative identification of the phenolic compounds present in the hydroethanolic extracts obtained
from leaves, stems, and flowers of C. macrocarpa. The quantification of each identified compound is
presented in Table 2. An exemplificative phenolic profile of the hydroethanolic extract prepared from
leaves is presented in Figure 1.
Thirty phenolic compounds were tentatively identified in the hydroethanolic extracts prepared
from C. macrocarpa leaves, stems, and flowers: nine phenolic acids (chlorogenic, coumaric, and syringic
coumaric acid derivatives), thirteen flavonols (kaempherol and quercetin derivatives), and eight
flavan-3-ols ((epi)-catechin derivatives). To the author’s best knowledge, all the phenolic compounds
were tentatively identified for the first time in the hydroethanolic extracts of C. macrocarpa.
Phenolic acids were found in higher amounts in the hydroethanolic extract of flowers, and in very
close amounts to flavanols in the same extract, while leaves showed the lowest amount of phenolic
acids. Four chlorogenic acid derivatives (peaks 1, 5, 6, and 8), four p-coumaric acid derivatives (peaks 2,
4, 13, and 15), and one syringic acid derivative (peak 3) were tentatively identified. Peaks 1, 5, 6, and 8
([M −H]− at m/z 353) were tentatively identified as 3-O-caffeoylquinic acid (peak 1), 4-O-caffeoylquinic
acid (cis and trans, peak 5 and 6, respectively), and 5-O-caffeoylquinic acid (peak 8). The assignments
of the different caffeoylquinic acid isomers were made using the hierarchical key system previously
reported by Clifford et al. (2003) and Clifford et al. (2005) [11,12]. Moreover, 5-O-caffeoylquinic acid
(peak 8) was positively identified in comparison with the available commercial standard. Peaks 2, 4, 13,
and 15 ([M −H]− at m/z 337) were tentatively identified according to their MS2 fragmentation as cis and
trans 3-p-coumaroylquinic acid, and cis and trans 5-p-coumaroylquinic acid, respectively, as previously
reported by Clifford et al. (2003) and Clifford et al. (2005) [11,12]. The identification of the compounds
2/4, 5/6, and 13/15 as cis/trans isomers, was based on experimental results previously published by
our research group [13], also following the information described by Clifford and coworkers [14,15]
regarding these isomers. The hydroxycinnamoyl cis and trans derivatives were distinguished, after
UV irradiation (366 nm, 24 h) of these acids in our laboratory [13]. Compound 3 with MS2 fragments
at m/z 197 ([syringic acid-H]−) resulting from the loss of a hexosyl moiety (−162 u) was tentatively
assigned as syringic acid hexoside.
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Table 1. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, and tentative identification of the phenolic
compounds present in the hydroethanolic extracts of C. macrocarpa leaves, stems, and flowers.
Peak Rt (min) λmax (nm) [M − H]− (m/z) MS2 (m/z) Tentative Identification
1 4.65 324 353 191(100),179(45),161(15),135(10) 3-O-Caffeolyquinic acid
2 5.16 310 337 191(100),173(3),161(5) cis 3-p-Coumaroylquinic acid
3 5.21 284 359 239(95),197(100),181(6),153(10),137(5) Syringic acid hexoside
4 5.34 290 337 191(100),173(5),161(5) trans 3-p-Coumaroylquinic acid
5 6.31 287 353 191(32),173(100),161(5),135(5) cis 4-O-Caffeolyquinic acid
6 6.8 325 353 191(75),173(100),161(12),135(5) trans 4-O-Caffeolyquinic acid
7 7.35 281 577 425(100),289(13) Type B (epi)catechin dimer
8 8.1 325 353 191(100),179(35),161(5),135(5) 5-O-Caffeolyquinic acid *
9 9.01 280 577 425(100),289(19) Type B (epi)catechin dimer
10 9.45 266,347 755 593(20),285(100) Kaempherol-O-hexoside-O-rutinoside
11 10.26 280 865 451(14),425(16),407(12),289(11) Type B (epi)catechin trimer
12 11.47 280 1153 865(78),577(35),575(43),289(5) Type B (epi)catechintetramer
13 10.77 284 337 191(100),173(5),161(5) cis 5-p-Coumaroylquinic acid
14 11.49 280 1153 865(82),577(24),575(36),289(5) Type B (epi)catechin tetramer
15 12.15 310 337 191(100),173(3),161(3) trans 5-p-Coumaroylquinic acid
16 12.41 280 865 451(15),425(13),407(17),289(7) Type B (epi)catechin trimer
17 12.9 280 863 711(26),573(61),451(12),411(5),289(22) Type A (epi)catechin trimer
18 13.1 267,347 739 593(100),285(25) Kaempferol-O-deoxyhexoside-O-deoxyhexosyl-hexoside isomer 1
19 13.35 280 1153 865(54),577(23),575(24),289(5) Type B (epi)catechin tetramer
20 13.96 265,352 755 609(100),301(25) Quercetin-O-deoxyhexoside-O-deoxyhexosyl-hexoside
21 14.07 266,357 739 593(100),285(25) Kaempferol-O-deoxyhexoside-O-deoxyhexosyl-hexoside isomer 2
22 14.7 257,352 609 301(100) Quercetin-O-deoxyhexosyl-hexoside isomer 1
23 15.62 280,339 739 285(100) Kaempferol-O-di-deoxyhexoside-hexoside
24 15.95 271,344 575 285(100) Acetylkaempherol-O-malonylhexoside
25 16.09 266,357 739 593(100),285(25) Kaempferol-O-deoxyhexoside-O-deoxyhexosyl-hexoside isomer 3
26 16.39 257,348 739 593(100),285(25) Kaempferol-O-deoxyhexoside-O-deoxyhexosyl-hexoside isomer 4
27 16.88 266,352 609 301(100) Quercetin-O-deoxyhexosyl-hexoside isomer 2
28 17.1 257,354 609 301(100) Quercetin-3-O-rutinoside *
29 19.17 266,346 593 285(100) Kaempherol-O-deoxyhexosyl-hexoside
30 20.32 266,346 593 285(100) Kaempherol-3-O-rutinoside *
* Compounds identified and quantified according to their chromatographic characteristics by comparison to those obtained with standard compounds.
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Table 2. Quantification (mg/g of extract) of the phenolic compounds present in the hydroethanolic
extracts of C. macrocarpa leaves, stems, and flowers.
Peak Leaves Stems Flowers
1 nd 0.49 ± 0.01 nd
2 0.25 ± 0.01 nd nd
3 nd 0.34 ± 0.01 nd
4 0.34 ± 0.01 b nd 0.6 ± 0.01 a
5 0.26 ± 0.004 c 0.61 ± 0.02 b 3.1 ± 0.1 a
6 0.5 ± 0.02 b 2.28 ± 0.02 a nd
7 2 ± 0.1 b 6.4 ± 0.2 a nd
8 nd nd 0.17 ± 0.01
9 nd 2.88 ± 0.01 nd
10 nd nd 0.48 ± 0.02
11 1.9 ± 0.1 b 6.09 ± 0.02 a nd
12 2.9 ± 0.1 nd nd
13 nd 0.97 ± 0.01 b 1.21 ± 0.02 a
14 nd 7.3 ± 0.2 nd
15 nd nd 0.49 ± 0.02
16 1.9 ± 0.1 b 3.7 ± 0.1 a nd
17 1.57 ± 0.05 b 4.9 ± 0.2 a nd
18 nd nd tr
19 2.2 ± 0.1 b 3.9 ± 0.1 a nd
20 1.79 ± 0.03 1.03 ± 0.01 nd
21 nd nd tr
22 nd nd tr
23 1.03 ± 0.01 nd nd
24 1.1 ± 0.03 nd nd
25 nd nd tr
26 nd nd 1.6 ± 0.1
27 tr nd nd
28 1.86 ± 0.04 b 2.6 ± 0.1 a 1.48 ± 0.01 c
29 nd nd tr
30 tr nd 1.73 ± 0.03
TPA 1.35 ± 0.04 c 4.68 ± 0.01 b 5.5 ± 0.1 a
TF3O 12.5 ± 0.2 b 35.1 ± 0.2 a nd
TF 5.7 ± 0.1 a 3.6 ± 0.1 c 5.3 ± 0.1 b
TPC 19.6 ± 0.3 b 43.4 ± 0.1 a 10.8 ± 0.2 c
tr—traces; nd—not detected. Standard calibration curves: caffeic acid (y = 168823x − 161172, R2 = 0.9939; peaks
1, 5, 6, and 8); catechin (y = 84950x − 23200, R2 = 0.9999; peaks 7, 9, 11, 12, 14, 16, 17, and 19); p-coumaric acid
(y = 301950x + 6966.7, R2 = 0.9999; peaks 2, 4, 13, and 15); quercetin-3-O-glucoside (y = 34843x − 160173, R2 =
0.9998; peaks 20, 21, 24, and 25); quercetin-3-O-rutinoside (y = 13343x + 76751, R2 = 0.9998; peaks 10, 18, 22, 23,
26, 27, 28, 29, 30, and 31). TPA—total phenolic acids; TF3O—total flavan-3-ols; TF—total flavonols; TPC—total
phenolic compounds.
Flavonol glycoside derivatives of quercetin (MS2 fragment at m/z 301) and kaempferol (MS2
fragment at m/z 285) were the main molecules present in this family of phenolic compounds.
Quercetin-3-O-rutinoside (rutin; peak 28) and kaempferol-3-O-rutinoside (peak 30) were identified
upon comparison of their chromatographic characteristics with available commercial standards.
These compounds have already been identified in the Apocyneaceae family [16].
Peaks 18, 21, 25, and 26 ([M − H]− at m/z 739) and 20 ([M − H]− at m/z 755) provided the same
consequently fragmentation losses of a deoxyhexosyl unit (146 u) and deoxyhexosyl-hexosyl unit (308 u),
indicating the location of each residue on different positions of the aglycones of kaempferol and quercetin,
respectively, being tentatively identified as kaempferol-O-deoxyhexoside-O-deoxyhexosyl-hexoside
isomers 1, 2 3, and 4, and quercetin-O-deoxyhexoside-O-deoxyhexosyl-hexoside, respectively. Peak
23 also showed a pseudomolecular ion [M − H]− at m/z 739, presenting a unique MS2 fragment
at m/z 285 (−454 u, which corresponded to 146 + 146 u + 162 u) indicating that the three sugar
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units were linked together in the same oxygen position of the aglycone, and in this particular
case, kaempferol, being tentatively identified as kaempferol-O-di-deoxyhexosyl- hexoside. Peak
24 presented a pseudomolecular ion [M − H]− at m/z 575, releasing an MS2 fragment at m/z 285,
corresponding to the loss of acetyl (42 u), malonyl (86 u), and hexosyl (162 u) residues, being
tentatively identified as acetylkaempherol-O-malonylhexoside. Peaks 22 and 27 ([M − H]− at m/z
609; MS2 at m/z 301) and 29 ([M − H]− at m/z 593; at m/z 301) showed a single MS2 fragment that
indicated the loss of 308 u, corresponding to two sugar units linked together (deoxyhexosyl-hexoside
moieties), being tentatively identified as quercetin-O-deoxyhexosyl-hexoside isomer 1 and 2, and
kaempherol-O-deoxyhexosyl-hexoside, respectively. Peak 10 ([M − H]− at m/z 755) fragmented at m/z
593 (−162 u, hexosyl unit) and 285 (−308 u, deoxyhexosyl-hexoside unit), being tentatively identified
as kaempherol-O-hexoside-O-deoxyhexosyl-hexoside.
Flavan-3-ols were the main family of phenolic compounds present in the hydroethanolic extracts
of stems of C. macrocarpa; not being detected in the flower samples. Peaks 7, 9, 11, 12, 14, 16, 17,
and 19 were tentatively identified based on their chromatographic characteristics (pseudomolecular
analysis and MS2 fragmentation pattern) coherent with B-type (epi)catechin derivatives. Thus, they
were tentatively identified as B-type (epi)catechin dimers (peaks 7 and 9, [M − H]− at m/z 577), trimers
(peaks 11 and 16, [M − H]− at m/z 865), and tetramers (peaks 12, 14, and 19, [M − H]− at m/z 1153) [17].
Peak 17 was tentatively identified based on the information found in the literature as a (epi)catechin
trimer with a type-A linkage, thus being assigned as an A-type (epi)catechin trimer [18].
The phenolic profile of the three plant parts was relatively similar; nevertheless, they all presented
different major compounds. For the leaves, cis 5-p-coumaroylquinic acid (peak 13, 2.9 mg/g extract)
was the major molecule, while trans 5-p-coumaroylquinic acid (peak 15, 7.3 mg/g extract) was the major
compound found in stems, and cis 4-O-caffeolyquinic acid (peak 5, 10.35 µg/g extract) was the main
compound found in flowers.
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Figure 1. Phenolic profile of the hydroethanolic extract of C. macrocarpa leaves recorded at 280 nm (A)
and 370 nm (B) obtained by HPLC-DAD/ESI-MS.
2.2. Bioactivities of the Hydroethanolic Extracts of Leaves, Stems, and Flowers
Results regarding in vitro antioxidant activity of the ethanol/water (80:20 v/v) extracts prepared
from leaves, stems, and flowers of C. macrocarpa are described in Table 3.
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Table 3. Antioxidant, cytotoxic, anti-inflammatory, and antibacterial activities of hydroethanolic extracts of C. macrocarpa leaves, stems, and flowers, and their
correlation with the families of the phenolic compounds identified (mean ± SD).
Leaves Stems Flowers
Correlation Factor r2
TPA TF3O TF TPC
Antioxidant activity EC50 values (µg/mL) A
DPPH scavenging activity 26 ± 1 b 281 ± 1 a 223 ± 6 a 0.887 w/n 0.862 m
Reducing power 36 ± 1 b 33 ± 1 a 279 ± 4 b w/n 0.940 w/n 0.995
β-carotene bleaching inhibition 300 ± 1 b 270 ± 10 b 1107 ± 47 a m 0.781 0.719 m
TBARS inhibition 15.4 ± 0.1 b 12.1 ± 0.1 c 92.5 ± 0.1 a m 0.794 0.718 m
Cytotoxicity GI50 values (µg/mL) B
MCF-7 (breast carcinoma) 167 ± 2 a 70.38 ± 0.03 c 95.25 ± 0.01 b 0.862 w/n 0.846 m
NCI-H460 (non-small cell lung carcinoma) 120 ± 1 a 58.7 ± 0.2 c 68 ± 1 b 0.911 w/n 0.898 m
HeLa (cervical carcinoma) 101 ± 1 a 52.1 ± 0.3 c 75 ± 1 b 0.721 m m 0.781
HepG2 (hepatocellular carcinoma) 152 ± 3 a 89 ± 1 b >400 0.943 w/n 0.953 w/n
PLP2 (non-tumour porcine liver primary cells) >400 >400 >400 - - - -
Anti-inflammatory activity IC50 values (µg/mL) C
NO production 179 ± 6 c 208 ± 9 a 196 ± 4 b m w/n w/n w/n
Antibacterial activity MIC values (mg/mL)
Gram-negative bacteria
Escherichia coli D 5 10 10 0.961 w/n 0.952 w/n
Escherichia coli ESBL E 20 20 20 - - - -
Klebsiella pneumoniae D >20 >20 >20 - - - -
Klebsiella pneumoniae ESBL D >20 >20 >20 - - - -
Morganella morganii D 10 10 20 0.720 0.772 0.774 w/n
Pseudomonas aeruginosa 20 20 20 - - - -
Gram-positive bacteria
Enterococcus faecalis F 1.25 1.25 5 0.720 0.772 0.774 w/n
Listeria monocytogenes G 2.5 0.625 20 m 0.825 m m
MRSA *,F 2.5 2.5 20 0.720 0.772 0.742 m
MSSA F 5 2.5 10 w/n 0.938 m 0.852
A Trolox EC50 values: 43.03 ± 1.71 µg/mL (DDPH), 29.62 ± 3.15 µg/mL (reducing power), 2.63 ± 0.14 µg/mL (β-carotene bleaching inhibition), and 3.73 ± 1.9 µg/mL (TBARS inhibition);
B Ellipticine GI50 value: 0.91 ± 0.04 µg/mL (MCF-7), 1.03 ± 0.09 µg/mL (NCI-H460), 1.91 ± 0.06 µg/mL (HeLa), 1.1 ± 0.2 µg/mL (HepG2), and 3.2 ± 0.7 µg/mL (PLP2); C Dexamethaxone EC50
value: 16 ± 1 µg/mL. S—susceptible; I—intermediate; R—resistant. This classification was made according to the interpretative breakpoints suggested by Clinical and Laboratory Standards
Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST): D Amoxicillin/Clavulanic acid (E. coli ≤ 8/4, S; K. pneumoniae ≤ 8/4, S; K. pneumoniae ESBL ≥
32, R; M. morganii > 16/8, R); E Amikacin (E. coli ESBL 16, I); F Vancomycin (E. faecalis, MRSA, and MSSA ≤ 2, S); G Ampicillin (L. monocytogenes ≤ 0.2, S). In each row and for the different
extraction procedure, different letters mean significant differences (p < 0.05). Data shown on correlation factor only considered the strong and very strong correlations ((0.7–0.9) and > 0.9,
respectively); m—moderate correlations ((0.5–0.7); w/n—weak and negligible correlations ((0.3–0.5) and (0–0.3), respectively). MIC—minimum inhibitory concentration.
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Overall, all samples presented high antioxidant activity, but the statistical analysis did not show
significant differences that could allow to particularize a more potent plant part. However, observing
the four used methodologies, the leaves presented the lowest EC50 values for DPPH scavenging
activity, reducing power, and β-carotene bleaching inhibition (EC50 = 26 ± 1, 36 ± 1, and 300 ± 1
µg/mL, respectively), while for the TBARS assay, the stems showed the lowest EC50 value (12.1 ±
0.1 µg/mL). The antioxidant activity of methanolic extracts from leaves and stems of C. grandiflora
originated in Pakistan was previously reported, presenting similar results for DPPH scavenging activity
of leaves (0.2089 ±mg/mL), but lower results for stems (0.0615 mg/mL) [4]. The cytotoxic effects of
the hydroethanolic extracts prepared from C. macrocarpa were evaluated on non-tumour (PLP2) and
four human tumour cell lines, with the results being summarized in Table 3. It can be observed that
all samples exhibited anti-proliferative activity on the four tested tumour cell lines with GI50 values
ranging between 52.1 ± 0.3 and 167 ± 2 µg/mL, with the exception of the hydroethanolic extract of
the flowers against HepG2. Unlike the antioxidant activity, the stems showed the lowest GI50 values
in all the cell lines studied. It is worthwhile mentioning that any of the samples exhibited toxicity
against the normal liver cell line (PLP2), up to the maximal tested concentration (GI50 > 400 µg/mL).
Khatun et al. (2017) [19] investigated C. macrocarpa methanolic extract, which reduced the viability of
adenocarcinoma cell lines (SW-480 and SW-48) with IC50 values of 140.6 and 376.6 µg/mL, respectively,
after 24 h of treatment, and 108.4 and 290.0 µg/mL, respectively, after 48 h of treatment. Sehar et al.
(2011) [20] studied the aqueous extract of C. spinarum stems and its n-butanol fraction, which exhibited a
potential cytotoxic effect on a wide range of human tumour cell lines, with apoptotic activity in human
leukaemia HL-60 cells, through the mitochondrial dependent pathway in HL-60 cells. In addition,
the methanolic extract of Carissa opaca Stapf ex Haines leaves and their fractions were tested against
MCF-7 breast cancer cell line, indicating that the fractions were more active than the crude extracts [21].
Carandinol extracted from the leaves of C. carandas exhibited significant in vitro cytotoxicity against
HeLa, PC-3, and 3T3 cell lines [22]. Lignans, carissanol, carinol, and nortrachelogenin extracted from
the stems of C. spinarum displayed cytotoxicity against breast (MCF-7) and lung (A549) tumour cell
lines [23].
The results regarding the anti-inflammatory activity of C. macrocarpa hydroethanolic extracts are
also summarized in Table 3. All the samples revealed inhibition of the NO production with higher
GI50 values in comparison with the positive control, and it can be verified that the highest activity was
observed in the leaves (GI50 = 179 ± 6 µg/mL). To the author’s best knowledge, there are no previous
reports regarding the anti-inflammatory activity of C. macrocarpa. However, the anti-inflammatory
activity of naringin isolate from the leaves of C. carandas was investigated in vivo by a carrageenan
induced hind rat pawedema model and in vitro by measuring its inhibitory effect on LPS induced
release of NO from RAW 264.7 macrophages. The results showed that naringin (compound not found
in our samples) exhibited potent inhibition of inflammation and inhibited LPS induced release of NO
from macrophages (IC50 = 6.4 µM) [24].
The hydroethanolic extracts of leaves, stems, and flowers of C. macrocarpa were tested for
their antimicrobial activity against selected clinical isolates, representing both Gram-positive and
Gram-negative bacteria. The results of the obtained minimum inhibitory concentration (MIC) values of
the hydroethanolic extracts of C. macrocarpa are presented in Table 3. Gram-positive bacteria were more
sensitive to the extracts presenting lower MIC values ranging from 0.625 to 20 mg/mL, and were more
susceptible to both leaves and stems. The best results among Gram-negative bacteria were observed for
Escherichia coli ESBL and Morganella morganii. Regarding Klebsiella pneumoniae and Klebsiella pneumoniae
ESBL, the extracts did not express any activity up to the maximal tested concentration. The antibacterial
activity of C. macrocarpa extracts is supported by the studies performed by Abbas et al. (2014) [4],
which reported a higher MIC value in the methanolic extracts of C. macrocarpa stems and leaves against
three pathogenic microorganisms (E. coli, Staphylococcus aureus, and Staphylococcus epidermidis), with
MIC values ranging between 0.39 and 1.88 mg/mL.
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Table 3 also presents the Pearson’s correlation analysis between the bioactivities and the sum
of total phenolic acid derivatives, total flavan-3-ols, total flavonols, and total phenolic compounds.
The results with a confidence level below 70% are not shown in the table, being classified as a
moderate correlation (confidence level between 50% and 70%) and weak and negligible correlations
(confidence level between 50% and 30% and between 30% and 0%, respectively). Regarding antioxidant
activity, it can be observed that flavan-3-ols had the highest correlations with β-carotene bleaching
inhibition and TBARS assay (r2 = 0781, and 0794, respectively), while DPPH scavenging activity
presented a higher correlation to the phenolic acids (r2 = 0.887), and reducing power to the total
phenolic compounds (r2 = 0.995). The antioxidant potential of flavan-3-ols derivatives has been widely
reported [25]; however, because of the structural diversity of these type of compounds, their in vivo
activity can be very different, which is the reason they did not correlate so strongly with the biochemical
assay of β-carotene bleaching inhibition and TBARS. Regarding the cytotoxic activity, phenolic acids
showed correlations with all the studied cell lines, although showing a higher correlation with MCF-7
and NCI-H460 (r2 = 0.862 and 0.911, respectively). For HeLa and HepG2 cell lines, the highest
correlation levels were observed with total phenolic compounds (r2 = 0.781) and flavonols (r2 = 0.953),
respectively. Finally, the correlations on the antimicrobial activity revealed that it is with Gram-negative
bacteria that phenolic compounds correlate more, with values that ranged between r2 = 0.720 and
0.938. However, the results obtained for E. coli showed a correlation level of r2 = 0.961 and r2 = 0.952
with the phenolic acids and flavonols, respectively, a much higher correlation than those observed for
the other Gram-negative bacteria. In the groups of phenolic acids and flavonols, no compound stood
out and, therefore, perhaps synergetic effects of all compounds are responsible for the high correlations
observed. However, the biological properties of hydroxycinnamic acids and quercetin and kaempferol
derivatives have already been abundantly observed and described; notwithstanding, the synergies
that occur in natural extracts may favour the biological properties.
3. Materials and Methods
3.1. Plant Material and Preparation of the Hydroethanolic Extracts
The samples of Carissa macrocarpa (Eckl.) A.DC. (leaves, stems, and flowers) were collected in
Monastir, Tunisia during 2016. The samples were dried until at a constant weight in an incubator at
35 ◦C. Then, the plant material was ground to approximately 40 mesh, and the homogeneous samples
were stored in a desiccator protected from light.
The hydroalcoholic extract was obtained by maceration using aqueous ethanolic solution (80%,
v/v; 30 g/mL) as the extraction solvent, applying the previous conditions reported by the authors
(Barros et al., 2013). After filtration (Whatman n◦4 filter), the solvent was first evaporated at 40 ◦C,
under reduced pressure, in a rotary evaporator (Büchi R-210, Flawil, Switzerland) and the residual
solvent was removed in a freeze drier (−49 ◦C, 0.089 bar, during 48 h, FreeZone 4.5, Labconco, Kansas
City, MO, USA).
3.2. Phenolic Profile of the Hydroethanolic Extracts of Leaves, Stems, and Flowers
The dry extracts were re-suspended at a concentration of 5 mg/mL using aqueous ethanol (80%,
v/v) and filtered (0.2 µm disposable LC filter disk, 30 mm, nylon). Afterwards, the phenolic profile
was found by liquid chromatography with a diode-array detector (280, 330, and 370 nm wavelengths)
coupled to an electrospray ionization mass spectrometry operating in negative mode (Dionex Ultimate
3000 UPLC and Linear Ion Trap LTQ XL, Thermo Scientific, San Jose, CA, USA), as previously described
by the authors [26]. The phenolic compounds were identified according to their chromatographic
characteristics by comparison with those obtained with standard compounds and with literature.
Calibration curves of appropriate standards were obtained in the range of 200–5 µg/mL for the
quantitative analysis. The results were expressed in mg per g of extract (mg/g).
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3.3. Bioactivities of the Hydroethanolic Extracts of Leaves, Stems, and Flowers
3.3.1. Antioxidant Activity
The extracts were diluted in distilled water at a concentration of 10 mg/mL; then, successive
dilutions were carried out (5000 and 6.25µg/mL). The DPPH radical-scavenging activity, reducing power,
inhibition of β-carotene bleaching, and TBARS assay were the methodologies applied to determine the
antioxidant activity [27]. The results were expressed as EC50 values (sample concentration providing
50% of antioxidant activity) and Trolox was used as a positive control.
3.3.2. Cytotoxic Activity
The extracts were re-dissolved in water at a 8 mg/mL concentration and further diluted in the
range of 400 to 6.25 µg/mL. The cytotoxic properties were evaluated using four human tumor cell lines:
MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa (cervical carcinoma), and
HepG2 (hepatocellular carcinoma). A non-tumor cell line (PLP2) was also evaluated using a procedure
previously described in Abreu et al. (2011) [28]. Sulforhodamine B assay was carried out [29], with
Ellipticine used as positive control, and a negative control was provided by each suspension of cells.
The results were expressed in GI50 values (concentration that inhibited 50% of the cell proliferation).
3.3.3. Anti-Inflammatory Activity
The extracts were re-dissolved in water at a concentration of 8 mg/mL and then diluted in the
range of 400 to 6.25 µg/mL. A mouse macrophage-like cell line RAW 264.7 was used in this study and
the Griess Reagent System (GRS) kit was applied to determine the nitric oxide, measured at 515 nm
(ELx800 microplate reader, Bio-Tek Instruments, Inc; Winooski, VT, USA), as described previously [30].
The results were expressed in EC50 values (sample concentration providing 50% of inhibition of NO
production) and Dexamethasone was used as a positive control, while in negative controls, no LPS
was added.
3.3.4. Antibacterial Activity
The extracts were re-dissolved in water to obtain a stock solution of 100 mg/mL and then diluted
in the range of 20 to 1.25 µg/mL. The antimicrobial potential of the extracts was assessed using
five Gram-negative bacteria and three Gram-positive bacteria. For each bacteria, the minimum
inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined using
a colorimetric assay, as described by Svobodova et al. (2017) [31].
3.4. Statistical Analysis
Triplicates of the samples were assayed and three repetitions of each methodology were performed,
with the results being expressed as mean values and standard deviations (SD). The significant differences
between samples were evaluated using one-way analysis of variance (ANOVA) followed by Tukey’s
HSD Test with p = 0.05 (SPSS v. 23.0 program); when there were less than three samples, a Student´s
t-test was applied (p = 0.05). Furthermore, a Pearson’s correlation analysis between the bioactivities
and all the sum contents of the analysed compounds (total phenolic acid derivatives, total flavan-3-ols,
total flavonols, and total phenolic compounds) was carried out, with a 95% confidence level.
4. Conclusions
The results obtained showed that the different parts of C. macrocarpa can be used as sources
of phenolic compounds, with high bioactive potential to be exploited in the development of novel
pharmaceutical formulations, for example. Overall, among the thirty phenolic compounds identified
in the hydroethanolic extracts prepared from leaves, stems, and flowers of C. macrocarp, three distinct
families were found: phenolic acids, flavan-3-ols, and flavonols. The last-mentioned group presented
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the highest number of identified compounds; thus, flavan-3-ols showed the highest concentration in
stems (mainly owing to the presence of dimers, trimmers, and tetramers of (epi)-catechin). The phenolic
acids were found in higher amounts in flowers, mainly owing to the presence of 4-O-caffeoylquinic
acid. Leaves were distinguished by their high antioxidant and anti-inflammatory activity, as well as
bactericidal activity against E. coli. Stems presented a high cytotoxic activity and bactericidal effect
against Gram-positive bacteria. The high correlation between the bioactivities studied and the presence
of phenolic compounds was also proven, which meets consumer expectations about their health
and well-being. Overall, the underexplored parts of C. macrocarpa presented high intrinsic bioactive
properties, such as antioxidant, cytotoxic, anti-inflammatory, and antimicrobial activities, potentiated
by the presence of phenolic compounds. The added value of this plant can lead to its application in
several industries, with different outputs.
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